ALK and neoplasm: Therefore, in nude mice transplanted tumors in NCI-H3122 cells, the main mechanism of action of iruplinalkib may be to inhibit ALK phosphorylation, and then inhibit tumor growth by inhibiting the downstream JAK/STAT pathway.